Rapid Micro Biosystems, Inc.

NasdaqCM:RPID Stock Report

Market Cap: US$154.8m

Rapid Micro Biosystems Management

Management criteria checks 4/4

Rapid Micro Biosystems' CEO is Rob Spignesi, appointed in Oct 2014, has a tenure of 10.67 years. total yearly compensation is $1.31M, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth $52.89K. The average tenure of the management team and the board of directors is 4.4 years and 4 years respectively.

Key information

Rob Spignesi

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage48.81%
CEO tenure10.7yrs
CEO ownership0.03%
Management average tenure4.4yrs
Board average tenure4yrs

Recent management updates

Recent updates

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

May 27
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Apr 21
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
author-image

MilliporeSigma And Lonza Collaborations Will Expand Market Reach

The global agreement with MilliporeSigma is set to expand Growth Direct's market reach and potentially enhance supply chain efficiency, boosting future revenues.

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 05
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported And Analysts Have Been Lifting Their Price Targets

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Looks Just Right With A 70% Price Jump

Mar 02
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Looks Just Right With A 70% Price Jump

Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Jan 16
Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Nov 02
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

Oct 29
Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

Aug 03
A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Jun 30
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing

Oct 10

Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

May 09
Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

Mar 08
Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Feb 07
We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

CEO Compensation Analysis

How has Rob Spignesi's remuneration changed compared to Rapid Micro Biosystems's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$45m

Dec 31 2024US$1mUS$641k

-US$47m

Sep 30 2024n/an/a

-US$48m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$52m

Dec 31 2023US$2mUS$617k

-US$52m

Sep 30 2023n/an/a

-US$58m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$60m

Dec 31 2022US$2mUS$593k

-US$61m

Sep 30 2022n/an/a

-US$59m

Jun 30 2022n/an/a

-US$68m

Mar 31 2022n/an/a

-US$69m

Dec 31 2021US$1mUS$507k

-US$78m

Sep 30 2021n/an/a

-US$77m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$60m

Dec 31 2020US$1mUS$445k

-US$45m

Compensation vs Market: Rob's total compensation ($USD1.31M) is about average for companies of similar size in the US market ($USD1.62M).

Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.

CEO

Rob Spignesi (55 yo)

10.7yrs
Tenure
US$1,313,638
Compensation

Mr. Robert G. Spignesi Jr., also known as Rob, has been Chief Executive Officer, President and Director of Rapid Micro Biosystems, Inc. since October 2014. Mr. Spignesi is employed at SGG Partners, LLC. He...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Spignesi
CEO, President & Director10.7yrsUS$1.31m0.034%
$ 52.9k
Sean Wirtjes
Chief Financial Officer6.8yrsUS$762.89k0.62%
$ 965.7k
John J. Wilson
Chief Operating Officer4.4yrsUS$725.77k0.30%
$ 461.3k
Michael Beaulieu
Vice President of Investor Relations & Corporate Communicationsno datano datano data
James Xu
Senior VP of Legal & Secretaryno datano datano data
Julie Jarvie
Senior VP of Human Resourcesless than a yearno datano data
Jason Lukasek
Senior Vice President of Global Commercialless than a yearno datano data
4.4yrs
Average Tenure
56yo
Average Age

Experienced Management: RPID's management team is considered experienced (4.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Spignesi
CEO, President & Director10.7yrsUS$1.31m0.034%
$ 52.9k
Natale Ricciardi
Independent Director9.3yrsUS$76.55k0.033%
$ 51.2k
Richard Kollender
Independent Director6.7yrsUS$79.05k0.22%
$ 346.2k
Kirk Malloy
Independent Chairman of Board1.9yrsUS$124.05k0.15%
$ 230.2k
Melinda Pei
Independent Director4yrsUS$84.05k0.13%
$ 194.4k
Inese Lowenstein
Independent Director3.5yrsUS$81.55k0.056%
$ 87.0k
Dafni Bika
Independent Directorless than a yearno datano data
4.0yrs
Average Tenure
57yo
Average Age

Experienced Board: RPID's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/29 12:49
End of Day Share Price 2025/06/27 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rapid Micro Biosystems, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tycho PetersonJ.P. Morgan
Paul KnightKeyBanc Capital Markets Inc.
Tejas SavantMorgan Stanley